Has Bruce Friedman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $629,289 in general payments to Bruce Friedman, MD across 649 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Bruce Friedman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Bruce Friedman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Bruce Friedman, MD

Critical Care Medicine · Augusta, GANPI 1417939315

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $471,442 of the $629,289 with a category attached, or 74.9%. 32 manufacturers reported payments, led by Shionogi Inc at 27.4% of the total. Reporting peaked in 2019 at $221,239 and has fallen 85.7% since, to $31,627 in 2025. Among critical care medicine clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$629,289in general payments, 2019–2025

Across 649 payments — averaging $969.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Shionogi Inc$172K
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$115K
Acelrx Pharmaceuticals, Inc.$60K
La Jolla Pharmaceutical Company$58K
Portola Pharmaceuticals, LLC$54K
Paratek Pharmaceuticals, Inc.$47K
plus $123K from 26 others

$23,650in research payments, 2019–2025

Across 3 payments — averaging $7883.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Shionogi Inc$24K

What the payments were for

Consulting fees$47,3818%
Speaking & faculty fees$471,44275%
Travel & lodging$96,73215%
Food & beverage$13,7102%
Education$250%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Shionogi Inc	147	$172,168
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	103	$115,095
Acelrx Pharmaceuticals, Inc.	80	$60,476
La Jolla Pharmaceutical Company	32	$58,253
Portola Pharmaceuticals, LLC	60	$53,912
Paratek Pharmaceuticals, Inc.	55	$46,678
Melinta Therapeutics, LLC	39	$28,046
Merck	41	$22,083
Astellas Pharma US Inc	15	$16,226
Medline Industries LP	11	$13,949
Tetraphase Pharmaceuticals, Inc.	7	$11,215
AstraZeneca(2 entities)	11	$8,881
BTG International Inc.	5	$7,683
AbbVie	17	$5,492
Regeneron Healthcare Solutions, Inc.	2	$2,750
C. R. Bard, Inc. & Subsidiaries	2	$2,510
Baudax Bio Inc.	1	$1,105
Cipla USA Inc.	2	$680
Kerecis Limited	2	$477
Bard Peripheral Vascular, Inc.	1	$300
Bard Access Systems, Inc.	1	$300
Bioventus LLC	1	$187
Cook Medical LLC	3	$182
Avita Medical Americas, LLC	1	$157
Ambu Inc.	1	$130
Trevena, Inc.	1	$80
OVIK Health, LLC	1	$67
Sientra, Inc.	1	$65
Smith+Nephew	3	$58
Potrero Medical, Inc.	1	$40
Johnson & Johnson	1	$26
Bioxcel Therapeutics, Inc.	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$629,289 in reported general payments places this provider in the 95th percentile of 265 critical care medicine providers in Georgia.

See all critical care medicine providers in Georgia →

Medicare billing

Part B allowed, 2024

$54,653

Medicare patients

Services billed

384

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other critical care medicine in Augusta

Gabriel ThorntonAugusta$5K
Anthony RamageAugusta$4K
Charles OribaborAugusta$4K
Amrita JariwalaAugusta$2K
Salman FidahusseinLagrange$852K
Gregory MauldinSnellville$221K
Ramzy RimawiAtlanta$72K
Rafael Alba YunenBrunswick$58K
April McDonaldGainesville$41K
Matthew SchmittAtlanta$32K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →